Does High-Dose Buprenorphine Cause Respiratory Depression?: Possible Mechanisms and Therapeutic Consequences

Author： Mégarbane Bruno   Hreiche Raymond   Pirnay Stéphane   Marie Nicolas   Baud Frédéric J.  

Publisher： Adis International

ISSN： 1176-2551

Source： Adverse Drug Reactions & Toxicological Reviews (now known as Toxicological Reviews), Vol.25, Iss.2, 2006-01, pp. : 79-85

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

High-dose tocopherol increases all-cause mortality

By  

Inpharma, Vol. 1, Iss. 1464, 2004-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Pharmacodynamics of High-Dose Chemotherapy

By  

Current Drug Metabolism, Vol. 2, Iss. 1, 2001-03 ,pp. : 53-66

Bentham Science Publishers

Access to resources Recommend Favorite

Mechanism-Based Pharmacokinetic-Pharmacodynamic Modelling of the Reversal of Buprenorphine-Induced Respiratory Depression by Naloxone: A Study in Healthy Volunteers

By Yassen Ashraf  

Clinical Pharmacokinetics, Vol. 46, Iss. 11, 2007-01 ,pp. : 965-980

Adis International

Access to resources Recommend Favorite

Candidate Mechanisms for Regression of Coronary Atherosclerosis with High-Dose Statins: Insight from Intravascular Ultrasonography Trials

By Sipahi Ilke   Tuzcu E. Murat  

American Journal of Cardiovascular Drugs, Vol. 8, Iss. 6, 2008-01 ,pp. : 365-371

Adis International

Access to resources Recommend Favorite

Participant Characteristics and Buprenorphine Dose

By Hillhouse Maureen   Canamar Catherine P.   Doraimani Geetha   Thomas Christie   Hasson Albert   Ling Walter  

The American Journal of Drug and Alcohol Abuse, Vol. 37, Iss. 5, 2011-09 ,pp. : 453-459

Informa Healthcare

Access to resources Recommend Favorite